Glycated Human Serum Albumin Isolated from Poorly Controlled Diabetic Patients Impairs Cholesterol Efflux from Macrophages: An Investigation by Mass Spectrometry
Authors:
- Gabriela CastilhoGCGabriela Castilho
- Camila H SartoriCSCamila H Sartori
- Adriana Machado-LimaAMAdriana Machado-Lima
- Edna R NakandakareENEdna R Nakandakare
- Maria Lucia C Corrêa-GiannellaMCMaria Lucia C Corrêa-Giannella
- Marco RoversoMRMarco Roverso
- Simona PorcuSPSimona Porcu
- Annunziata LapollaAnnunziata Lapolla
- Pietro TraldiPTPietro Traldi
- Marisa PassarelliMPMarisa Passarelli
- 1 June 2015
- journal article
- Published by SAGE Publications in European Journal of Mass Spectrometry
- Vol. 21 (3) , 233-244
Abstract
Advanced glycation end-products impair ABCA-1-mediated cholesterol efflux by eliciting inflammation, the generation of reactive oxygen species and endoplasmatic reticulum (ER) stress. The glycation level of human serum albumin (HSA) from type 1 and type 2 diabetic patients was determined by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry and related to possible impairment of ER function and cellular cholesterol efflux. Comparison of the MALDI spectra from healthy and diabetic subjects allowed us to determine an increased HSA mean mass of 1297 Da for type 1 and 890 Da for type 2. These values reflect a mean condensation of at least 8 glucose units and 5 glucose units, respectively. Mouse peritoneal macrophages were treated with HSA from control, type 1 and type 2 diabetic subjects in order to measure the expression of Grp78, Grp94, protein disulfide isomerase (PDI), calreticulin (CRT), and ABCA-1. 14C-cholesterol overloaded-J774 macrophages were treated with HSA from control and diabetic subjects and further incubated with apo A-1 to determine the cholesterol efflux. Combined analyses comprising HSA from type 1 and type 2 diabetic patients were performed in cellular functional assays. In macrophages, PDI expression increased 89% and CRT 3.4 times in comparison to HSA from the control subjects. ABCA-1 protein level and apo A-I-mediated cholesterol efflux were, respectively, 50% and 60% reduced in macrophages exposed to HSA from type 1 and type 2 diabetic patients when compared to that exposed to HSA from control subjects. We provide evidence that the level of glycation that occurs in albumin in vivo damages the ER function related to the impairment in macrophage reverse cholesterol transport, and so contributes to atherosclerosis in diabetes.Keywords
This publication has 34 references indexed in Scilit:
- Advanced glycated albumin impairs HDL anti-inflammatory activity and primes macrophages for inflammatory response that reduces reverse cholesterol transportBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetesVascular Pharmacology, 2012
- Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA‐1‐mediated reverse cholesterol transportDiabetes/Metabolism Research and Reviews, 2012
- Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical updateActa Diabetologica, 2012
- ER stress is associated with reduced ABCA-1 protein levels in macrophages treated with advanced glycated albumin – Reversal by a chemical chaperoneThe International Journal of Biochemistry & Cell Biology, 2012
- Inhibition of Macrophage Oxidative Stress Prevents the Reduction of ABCA‐1 Transporter Induced by Advanced Glycated AlbuminLipids, 2012
- Advanced Glycation in macrophages induces intracellular accumulation of 7-ketocholesterol and total sterols by decreasing the expression of ABCA-1 and ABCG-1Lipids in Health and Disease, 2011
- Trends in the Risk for Coronary Heart Disease Among Adults With Diagnosed Diabetes in the U.S.Diabetes Care, 2011
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009